Shares of Sarepta Therapeutics have struggled for the past year due to concerns about the commercial potential of its gene ...
We recently published a list of 10 Firms Heavily Hit by Market Pessimism. In this article, we are going to take a look at ...
Shares of biotech company Sarepta Therapeutics (NASDAQ:SRPT) fell 24.9% in the pre-market session after the company reported ...
Cantor Fitzgerald reiterated their overweight rating on shares of Sarepta Therapeutics (NASDAQ:SRPT – Free Report) in a ...
Cargo was founded by two highly acclaimed cell-therapy researchers. The company raised over $500 million to develop ...
Deutsche Bank lowered the firm’s price target on Sarepta (SRPT) to $99 from $124 and keeps a Hold rating on the shares after the company ...
Cambridge-based Sarepta Therapeutics said Tuesday that a patient died while taking its closely watched gene therapy for ...
Regenxbio (RGNX) stock gains and Solid Biosciences (SLDB) stock falls after Sarepta Therapeutics' (SRPT) safety update on ...